Aidite said at an Aug. 25 results briefing that its implant business posted
modest growth in 1H26. Domestically the company is actively preparing to
participate in the second round of implant centralized procurement; overseas
expansion was stronger, led by the Middle East and Southeast Asia. Aidite said
it has completed channel network optimization and is reinforcing implant sales
strategy and its KOL team to support growth. On product strategy, the company
will prioritize the digital implant segment—which it sees as having more upside
than restorative—while advancing implant robotics as part of an integrated
digital-implant solution.
